Watertown, MA, United States of America

Radha Pertaub

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 6.4

ph-index = 5

Forward Citations = 84(Granted Patents)


Location History:

  • Somerville, MA (US) (2012 - 2014)
  • Watertown, MA (US) (2014 - 2018)

Company Filing History:


Years Active: 2012-2018

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations by Radha Pertaub in Eye Monitoring Technologies

Introduction

Radha Pertaub is an accomplished inventor based in Watertown, MA (US). She has made significant contributions to the field of ophthalmology through her innovative patents. With a total of 5 patents, her work focuses on advanced systems for monitoring photo active agents in the eye.

Latest Patents

One of Radha's latest patents is titled "Systems and methods for monitoring time based photo active agent delivery or photo active marker presence." This invention provides a monitoring system that measures the presence of a photo active marker by illuminating the eye to excite the marker and observing its characteristic emission. The systems incorporate Scheimpflug optical systems or slit lamp optical systems to capture cross-sectional images of the eye. This allows for monitoring the instantaneous distribution, diffusion pattern, and rate of uptake of a photo active agent applied to the eye. Furthermore, the monitored distribution can be utilized as feedback for a cross-linking system.

Career Highlights

Radha Pertaub works at Avedro, Inc., where she continues to develop her innovative ideas. Her work has been instrumental in advancing the understanding and treatment of eye conditions through the use of photo active agents.

Collaborations

Radha collaborates with notable colleagues, including David Muller and Ronald Scharf. Their combined expertise contributes to the success of their projects and innovations.

Conclusion

Radha Pertaub's contributions to eye monitoring technologies exemplify her dedication to innovation in the field. Her patents not only enhance the understanding of photo active agents but also pave the way for improved treatments in ophthalmology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…